AGE Annual EBIT
-$9.91 M
-$2.72 M-37.90%
31 December 2023
Summary:
As of February 5, 2025, AGE annual earnings before interest & taxes is -$9.91 million, with the most recent change of -$2.72 million (-37.90%) on December 31, 2023. During the last 3 years, it has risen by +$84.00 thousand (+0.84%).AGE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGE Quarterly EBIT
-$3.49 M
-$1.13 M-48.15%
31 December 2023
Summary:
As of February 5, 2025, AGE quarterly earnings before interest & taxes is -$3.49 million, with the most recent change of -$1.13 million (-48.15%) on December 31, 2023. Over the past year, it has dropped by -$1.70 million (-95.51%).AGE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGE TTM EBIT
-$9.91 M
-$1.70 M-20.75%
31 December 2023
Summary:
As of February 5, 2025, AGE TTM earnings before interest & taxes is -$9.91 million, with the most recent change of -$1.70 million (-20.75%) on December 31, 2023. Over the past year, it has dropped by -$2.72 million (-37.90%).AGE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGE EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.9% | -95.5% | -37.9% |
| 3 y3 years | +0.8% | -56.5% | +0.9% |
| 5 y5 years | +11.9% | -3.8% | +21.1% |
AGE EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +40.5% | +130.4% | +179.1% |
AgeX Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$9.91 M(+37.9%) | -$3.49 M(+48.2%) | -$9.91 M(+20.7%) |
| Sept 2023 | - | -$2.35 M(+24.7%) | -$8.21 M(+11.4%) |
| June 2023 | - | -$1.89 M(-13.6%) | -$7.37 M(+1.8%) |
| Mar 2023 | - | -$2.19 M(+22.5%) | -$7.24 M(+0.7%) |
| Dec 2022 | -$7.19 M(-4.0%) | -$1.78 M(+17.8%) | -$7.19 M(-1.1%) |
| Sept 2022 | - | -$1.51 M(-13.8%) | -$7.27 M(-2.1%) |
| June 2022 | - | -$1.75 M(-17.8%) | -$7.42 M(-5.7%) |
| Mar 2022 | - | -$2.14 M(+14.6%) | -$7.87 M(+5.2%) |
| Dec 2021 | -$7.49 M(-25.1%) | -$1.86 M(+11.6%) | -$7.49 M(-4.6%) |
| Sept 2021 | - | -$1.67 M(-24.1%) | -$7.85 M(-8.5%) |
| June 2021 | - | -$2.20 M(+25.8%) | -$8.58 M(-1.9%) |
| Mar 2021 | - | -$1.75 M(-21.5%) | -$8.74 M(-12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$9.99 M(-20.4%) | -$2.23 M(-7.1%) | -$10.00 M(-4.7%) |
| Sept 2020 | - | -$2.40 M(+1.3%) | -$10.49 M(-7.8%) |
| June 2020 | - | -$2.37 M(-21.3%) | -$11.37 M(-8.6%) |
| Mar 2020 | - | -$3.01 M(+10.8%) | -$12.45 M(-0.9%) |
| Dec 2019 | -$12.56 M(+11.7%) | -$2.72 M(-17.2%) | -$12.56 M(-4.9%) |
| Sept 2019 | - | -$3.28 M(-4.7%) | -$13.20 M(+8.9%) |
| June 2019 | - | -$3.44 M(+10.2%) | -$12.12 M(+12.1%) |
| Mar 2019 | - | -$3.12 M(-7.0%) | -$10.82 M(-3.8%) |
| Dec 2018 | -$11.24 M(+33.6%) | -$3.36 M(+52.5%) | -$11.24 M(+42.6%) |
| Sept 2018 | - | -$2.20 M(+3.2%) | -$7.89 M(+38.7%) |
| June 2018 | - | -$2.13 M(-39.9%) | -$5.68 M(+60.1%) |
| Mar 2018 | - | -$3.55 M | -$3.55 M |
| Dec 2017 | -$8.42 M | - | - |
FAQ
- What is AgeX Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for AgeX Therapeutics?
- What is AgeX Therapeutics annual EBIT year-on-year change?
- What is AgeX Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for AgeX Therapeutics?
- What is AgeX Therapeutics quarterly EBIT year-on-year change?
- What is AgeX Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for AgeX Therapeutics?
- What is AgeX Therapeutics TTM EBIT year-on-year change?
What is AgeX Therapeutics annual earnings before interest & taxes?
The current annual EBIT of AGE is -$9.91 M
What is the all time high annual EBIT for AgeX Therapeutics?
AgeX Therapeutics all-time high annual earnings before interest & taxes is -$7.05 M
What is AgeX Therapeutics annual EBIT year-on-year change?
Over the past year, AGE annual earnings before interest & taxes has changed by -$2.72 M (-37.90%)
What is AgeX Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of AGE is -$3.49 M
What is the all time high quarterly EBIT for AgeX Therapeutics?
AgeX Therapeutics all-time high quarterly earnings before interest & taxes is -$1.51 M
What is AgeX Therapeutics quarterly EBIT year-on-year change?
Over the past year, AGE quarterly earnings before interest & taxes has changed by -$1.70 M (-95.51%)
What is AgeX Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of AGE is -$9.91 M
What is the all time high TTM EBIT for AgeX Therapeutics?
AgeX Therapeutics all-time high TTM earnings before interest & taxes is -$3.55 M
What is AgeX Therapeutics TTM EBIT year-on-year change?
Over the past year, AGE TTM earnings before interest & taxes has changed by -$2.72 M (-37.90%)